September 22, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Look at Its 30.90% Revenue Growth and What It Means for Investors

Guardant Health, Inc. (GH), a key player in the Diagnostics & Research industry within the healthcare sector, is drawing significant attention from investors thanks to its remarkable revenue growth and..

BrightSpring Health Services (BTSG) Stock Analysis: Revenue Growth Shines Amid Potential Upside

BrightSpring Health Services, Inc. (BTSG) has positioned itself as a compelling player in the healthcare sector, specifically within the health information services industry. Headquartered in Louisville, Kentucky, BrightSpring operates through..

Corcept Therapeutics (CORT) Stock Analysis: Strong Buy Ratings and 67.97% Potential Upside Capture Investor Attention

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is currently capturing investor interest with its robust pipeline and substantial growth potential. Headquartered in Redwood City, California,..

Soleno Therapeutics (SLNO) Stock Analysis: An Eye on 116.89% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with its promising potential upside of 116.89%. As a clinical-stage biopharmaceutical company, Soleno Therapeutics is at the forefront of developing innovative..

Integer Holdings Corporation (ITGR): Analyst Consensus Signals Significant Growth Potential with a 36% Upside

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, specializes in the development and manufacturing of medical devices. With a market capitalization of $3.62 billion, Integer operates..

Avidity Biosciences, Inc. (RNA) Stock Analysis: 66% Upside Potential Draws Investor Attention

Avidity Biosciences, Inc. (NASDAQ: RNA) has emerged as a compelling player in the biotechnology sector, capturing investor interest with its innovative approach to RNA therapeutics. Specializing in antibody oligonucleotide conjugates..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 9.92% Potential Upside in the Biotech Arena

In the rapidly evolving world of biotechnology, Insmed Incorporated (NASDAQ: INSM) stands out as a significant player with a promising pipeline targeting rare diseases. As of the latest data, the..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: A 70% Potential Upside Awaits Investors

Investors with a keen eye on the biotech sector might want to take a closer look at Akero Therapeutics, Inc. (NASDAQ: AKRO), a company that has been making waves in..

STERIS plc (STE) Stock Analysis: Navigating a Promising Upside with 9.5% Potential for Investors

For investors eyeing opportunities in the healthcare sector, STERIS plc (NYSE: STE) stands out as a noteworthy contender. With a market capitalization of $24.5 billion, STERIS operates in the medical..

Waystar Holding Corp. (WAY): Investor Outlook with a 31.75% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is capturing attention in the healthcare sector with its innovative cloud-based software solutions for healthcare payments. As healthcare providers increasingly seek efficiency in financial operations,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Landscape with a 41% Potential Downside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, is facing a complex financial landscape that requires careful navigation by investors. With a market capitalization of..

Verona Pharma plc (VRNA): Investor Outlook and Analyst Consensus on a Biotech Powerhouse

Verona Pharma plc (NASDAQ: VRNA), a burgeoning player in the biotechnology sector, has captured investor attention with its strategic focus on respiratory therapies. Headquartered in London, this UK-based biopharmaceutical company..

Koninklijke Philips N.V. (PHG) Stock Analysis: Healthcare Giant with a 16.65% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, operates within the medical devices industry. With a market capitalization of $26.88 billion, this Dutch multinational is a significant..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 26% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a formidable player in the biotechnology sector, with a compelling narrative that has captured the attention of investors. With a market capitalization of..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 15.44% Upside Potential Amidst Challenging Metrics

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, stands at an intriguing juncture for investors. The company, with a market capitalization of $11.54 billion, operates across a..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A High-Valuation Biotech with Strong Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in RNA interference (RNAi) therapeutics, stands out in the biotechnology sector with a significant market capitalization of $59.45 billion. Based in Cambridge, Massachusetts,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating the Potential Upside in a Volatile Market

Investors have their eyes on iRhythm Technologies, Inc. (NASDAQ: IRTC), a standout player in the healthcare sector, particularly in the medical devices industry. Known for its pioneering work in ambulatory..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a Potential 52.51% Upside in the CNS Therapeutics Market

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, is making waves in the biotechnology sector with its promising pipeline and robust..

AstraZeneca PLC (AZN): Investor Outlook with a 14.54% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (AZN) stands prominently as a global leader in the healthcare sector, with a particular focus on the discovery, development, and commercialization of prescription medicines. With a market capitalization..

DexCom, Inc. (DXCM) Stock Analysis: A 51% Upside Potential and Strong Buy Consensus

For investors seeking promising opportunities in the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents a compelling case. As a leading player in the medical devices industry, DexCom specializes in continuous..

Search

Funds

September 22, 2025

Search

Funds

September 22, 2025

FTSE 100

Funds